Association for Behavior Analysis International

The Association for Behavior Analysis International® (ABAI) is a nonprofit membership organization with the mission to contribute to the well-being of society by developing, enhancing, and supporting the growth and vitality of the science of behavior analysis through research, education, and practice.

Search

19th Annual Autism Conference; New Orleans, LA; 2025

Program by Continuing Education Events: Saturday, January 18, 2025


 

Invited Paper Session #3
CE Offered: BACB/QABA/IBAO
Behavior Analysis in the Healthcare Ecosystem
Saturday, January 18, 2025
8:10 AM–9:00 AM
Sheraton New Orleans, Level 3, Napoleon Ballroom BC
📺   Streaming Status: recording available
Area: AUT; Domain: Service Delivery
Chair: M. Christopher Newland (Auburn University)
CE Instructor: M. Christopher Newland, Ph.D.
Presenting Author: STEVEN MERAHN (Union In Action, Inc.)
Abstract:

The growth of the applied behavior analysis (ABA)-based autism care system has forced the pediatric and behavior analytic communities into collaborative relationships where they 'share the care" of children with autism and their families, but do not have clear relationship practices, common principles of conduct, or mutual accountability. At the same time, the behavior analytic community is increasingly subject to working under principles, practices and cuture of the healthcare ecosystem with its own functions and operating model that may not be native to behavior analysis as a discipine or profession. This presentation will explore the risks of this knowledge/practice gap, and the opportunities inherent in the transformative integration of behavior analysis and pediatrics to affect outcomes for all children. Real-world examples will be used to explore the cultural, disciplinary, regulatory, and sustainability issues in such integration, and make specific programmatic recommendations to build mutually valuable bridges between the two professional disciplines, specifically related to the principles of collaborative treatment planning, care coordination, shared decision making, and 'whole-child' frameworks for outcomes measurement.

Instruction Level: Intermediate
Target Audience:

Behavior Analysts

Learning Objectives: At the conclusion of the presentation, participants will be able to: (1) Identify the role of ecosystem behavior and the structure of the healthcare environment on their function and performance as behavior analysts; (2) Effect changes in their model of care and behavior within the healthcare ecosystem to ensure better integration and acceptance of behavior analysis; (3) Advocate for expanded clinical applications of behavior analysis in healthcare beyond autism services.
 
STEVEN MERAHN (Union In Action, Inc.)
Dr. Merahn is a veteran physician-executive and a recognized thought leader in systems-based practice and healthcare interaction design, with special focus on health disparities populations and communities with complex health-related needs. He is currently the Medical Director for two NYS-based non-profit organizations exclusively dedicated to supporting individuals with intellectual and developmental disabilities (IDD) and their circles of support: Care Design NY, a care coordination organization health home serving almost 30,000 members and Partners Health Plan, a CMS-authorized managed care demonstration project for fully integrated IDD care. He is also a Strategic Advisor to UNIFI Autism Care. Trained as a pediatrician, Dr Merahn is Fellow of the American Academy of Pediatrics (AAP), a member of the Autism Subcommittee of the AAP Council on Children with Disabilities and the Primary Care Committee of the AAP Section on Developmental and Behavioral Pediatrics and the only physician on the Council of Autism Services Providers (CASP) Autism Commission on Quality. He is the former Chief Medical Officer for a national autism services provider, Chief Medical Officer of a national home-based primary care network and ACO serving complex/fragile and disabled patients, Senior Vice President and Senior Medical Director at Aetna’s Active Health Management Unit, and a Vice President at the Albert Einstein Healthcare Network in Philadelphia where he led their organizational transformation initiative. He began his career as a Senior Medical Director with the NYC Department of Health, working on policies and program in maternal/child health. Dr. Merahn is an established thought leader on healthcare transformation and a vocal advocate for health equity for socially disadvantaged communities. He is the author of Care Evolution: Essays on Health Care as a Social Imperative which advocates for health as a social imperative and for healthcare as a fundamentally human endeavor rooted in collaboration, systems innovation, and healthcare interaction design.
 
 
Invited Paper Session #4
CE Offered: PSY/BACB/QABA/IBAO
Autism and Epilepsy: Coincidence or Biomarker?
Saturday, January 18, 2025
9:10 AM–10:00 AM
Sheraton New Orleans, Level 3, Napoleon Ballroom BC
📺   Streaming Status: recording available
Area: AUT; Domain: Applied Research
Chair: Terry S. Falcomata (The University of Texas at Austin)
CE Instructor: Terry S. Falcomata, Ph.D.
Presenting Author: MOHAMMED ALDOSARI (Cleveland Clinic)
Abstract:

Autism spectrum disorder (ASD) and epilepsy are both neurological conditions that can significantly impact a child's development and overall well-being. While they may appear to be independent diagnoses, there is a higher co-occurrence rate than chance would predict. This presentation will explore the complex relationship between ASD and epilepsy, equipping therapists with the knowledge and tools to better support their clients who experience both conditions. The presentation will delve into the following key areas: • Prevalence and Risk Factors: We will examine the co-occurrence rates of ASD and epilepsy, exploring potential risk factors and underlying biological mechanisms. • Clinical Presentations: We will discuss the diverse ways in which epilepsy can manifest, including potential challenges in identifying and diagnosing epilepsy in individuals with ASD. • Treatment Considerations: We will explore the evidence-based practices for treating epilepsy to address the unique needs of this population. Here, we will also discuss potential side effects of anti-seizure medications and how they may impact behavior or learning, equipping applied behavior analysis (ABA) therapists to collaborate with the medical team for optimal treatment. • Emerging Technologies: We will explore the potential of using new technologies including AI analysis of EEG (electroencephalogram) data for early detection of ASD. This discussion will highlight the promise and limitations of new technologies, emphasizing their role as potential tools to support informed clinical decision-making. • Collaborative Care: We will emphasize the importance of collaboration between ABA therapists, neurologists, and other healthcare professionals in developing comprehensive treatment plans.

Instruction Level: Intermediate
Target Audience:

Therapists and physicians taking care of individuals with ASD

Learning Objectives: At the conclusion of the presentation, participants will be able to: (1) Describe the co-occurrence rates of ASD and epilepsy and identify potential risk factors for this dual diagnosis; (2) Explain the diverse clinical presentations of ASD and epilepsy, including the challenges of identifying and diagnosing co-occurring conditions; (3) Discuss evidence-based treatment approaches for both ASD and epilepsy, with a specific focus on adapting ABA therapy to meet the needs of clients with this dual diagnosis.
 
MOHAMMED ALDOSARI (Cleveland Clinic)
Dr. Aldosari has been a board-certified Pediatric Neurologist since 2003 and was certified by the American Board of Pediatrics in 2002. He received his Bachelor Degree of Medicine and Surgery from King Saud University, Riyadh, Saudi Arabia and he completed his first Pediatric Residency Program at King Faisal Specialist Hospital and Research Center in Riyadh. He subsequently completed a Pediatric Residency Program and Adult Neurology Program at the University of Minnesota, Minneapolis, Minnesota. Following completion of his residency training, Dr. Aldosari completed a Pediatric Neurology Fellowship Program at Duke University Medical Center, Durham, North Carolina. Dr. Aldosari began his career with an appointment as Consultant and Fellowship Program Director at the Section of Pediatric Neurology King Faisal Specialist Hospital & Research Center, in Riyadh, Saudi Arabia. In 2007, he was promoted to Head of Section of Pediatric Neurology at King Faisal Specialist Hospital & Research Center. In 2012, Dr. Aldosari accepted a Pediatric Neurologist position at Mercy Pediatric Neurology &Psychiatry Center in Des Moines, Iowa. In 2014, he accepted a position at the Cleveland Clinic where he is currently, Director of the Center for Pediatric Neurosciences. He is also a Clinical Assistant Professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. He also developed a large program focusing on the use of botulinum toxins to address intractable pediatric headaches and spasticity. Dr. Aldosari has a long standing interest in Autism Spectrum Disorders research and has worked with former colleagues in Riyadh to advance both their clinical and research programs. He is a member of the International Society for Autism Research as well as a member of the American Academy of Neurology. Dr. Aldosari is well published with over 30 articles and abstracts to-date. Dr. Aldosari is also a funded Autism researcher with unique projects focused on Innovative and Objective Screening and Diagnostic Tools for Autism Spectrum Disorders working with Cleveland Clinic Innovation, national and international collaborators.
 
 
Invited Paper Session #5
CE Offered: BACB/QABA/NASP/IBAO
Minimal Verbal Units Control in Reading: From Basic to Applied Researches and Implications for Attending Children With Autism Spectrum Disorder (ASD)
Saturday, January 18, 2025
10:30 AM–11:20 AM
Sheraton New Orleans, Level 3, Napoleon Ballroom BC
📺   Streaming Status: recording available
Area: AUT; Domain: Applied Research
Chair: M. Christopher Newland (Auburn University)
CE Instructor: M. Christopher Newland, Ph.D.
Presenting Author: MARTHA COSTA HÜBNER (University of São Paulo)
Abstract:

For Skinner (1957), if reading larger units, such as words, are taught, the control by smaller units, such as phonemes and syllables can emerge, without direct training. Basic researches during fifteen years have been conducting in order to verify this statement and check what are the relevant variables. Experiments were conducted at USP verbal operant laboratory (LEOV) in Brazil with pre-school children, from 3 to 4 years old. Through equivalence-based instruction and systematic recombination of minimal verbal units of disyllabic words in Portuguese, thirty neurotypical pre-school children learned to read twelve disyllabic words and were tested for generalization in reading new words, composed by the same units (syllables and letters) of the learned ones, with recombination of its positions in the words. The design was pre and post tests intra participants, but also with inter participants comparisons between several experimental variables effects upon 30 participant’s performances. Results were individually analyzed and showed that the main experimental variable to produce minimal verbal unit control in reading was the systematic recombination of these units in three sets of four disyllabic words. After this procedure was conducted, all children improved reading scores (next to 100% of accurate reading) with a completely new set of four disyllabic words. At the level of phoneme unit, teaching this unit only produced accurate reading of new words, when teaching phonemes was combined with systematic recombination of the syllable unit. Positive implications for practice will be pointed out, highlighting the possibility to teach reading to children with autism spectrum disorder (ASD) with few errors.

Instruction Level: Intermediate
Target Audience:

Behavior analysts

Learning Objectives: At the end of the presentation, participants will be able to: (1) Describe what is “minimal verbal unit control” in reading and describe examples of its application to persons with ASD; (2) Describe procedures (evidence based - from applied and basic researches), that can produce control by minimal verbal units in reading; (3) Describe specific teaching procedures of systematic recombination of phonemes, letters and syllables of words that produce recombinative and generalized reading, as well as describe its implications for ABA services.
 
MARTHA COSTA HÜBNER (University of São Paulo)
Dr. Hübner has graduated in Psychology at Catholic University, in São Paulo (PUCSP, 1979), Brazil, and completed her Master and Doctor Degrees in Experimental Psychology at USP (University of São Paulo, 1982 and 1990, respectively). Dr. Hübner’s master thesis (on autism and verbal behavior) and doctoral dissertation (on equivalence and reading) are considered to be the first ones with these themes in the history of Behavior Analysis in Brazil. She is currently a full professor at the University of São Paulo. She was president of the Brazilian Association of Psychology (SBP) from 2002 to 2005 and she coordinated the Graduate Program in Experimental Psychology at USP from 2005 to November 2012. She was also president of the Brazilian Association of Psychology and Behavioral Medicine. (ABPMC) from 2008 to 2011. In 2014, she was elected President of the Association for Behavior Analysis International (ABAI, from 2014 to 2017), having served on the Executive Board of ABAI from 2009 to 2014 (May) as an elected International Representative. She is a researcher at the National Institute of Science and Technology in Behavior, with studies about verbal behavior, equivalence, bidirectional naming and recombinative reading (INCT-ECCE). Dr. Hübner has been published scientific papers in the main national Journals and international journal, such as The Analysis of Verbal Behavior, Psychological Record, among others. Dr. Hübner has teaching, research and application experience, mainly in the following topics: verbal behavior, learning, reading, stimulus equivalence, recombinative reading, autism, both in basic and applied behavior analysis domains. In May 2018, she received the Award for "International Dissemination of Behavior Analysis", granted by ABAI. In May 2022, she also received the award for “Effective presentation of Behavior Analysis in the Mass Media”, from the same Association.
 
 
Invited Paper Session #10
CE Offered: BACB/QABA/IBAO
Profound Autism: A Diagnosis to Not Be Missed
Saturday, January 18, 2025
1:30 PM–2:20 PM
Sheraton New Orleans, Level 3, Napoleon Ballroom BC
📺   Streaming Status: recording not available by presenter request
Area: AUT; Domain: Applied Research
Chair: M. Christopher Newland (Auburn University)
CE Instructor: M. Christopher Newland, Ph.D.
Presenting Author: LEE WACHTEL (Kennedy Krieger Institute)
Abstract:

In 2021, the Lancet Commission on the future of care and clinical research in autism proposed the term “profound autism” to refer to autistic individuals with comorbid intellectual disability with IQ <50 and minimal-to-no language who require 24 hour supervision and assistance with activities of daily living. The profound autism rubric was meant to allow for a more accurate and precise autism diagnosis than what is currently offered within the DSM-5, with the goal of better characterization of all individuals across the autism spectrum in order to enhance clinical care, research and long-term outcomes for everyone. The Lancet Commission’s emphasis on diagnostic clarity was consistent with other scientific initiatives to establish clinically meaningful autism subtypes rather than erroneously lumping everyone together and potentially missing important distinctions carrying direct impact on autistic individuals, their families, global health and psychosocial functioning. Multiple issues are of particular and heightened concern for those with profound autism, including challenging and maladaptive behaviors, psychiatric comorbidities, vastly discrepant service needs with an associated nationwide dearth of such, and unequal representation in crucial research. While some autism advocates have decried “profound autism” as ableist and discriminatory, this stance is largely inconsistent with science and often paradoxically leads to the exclusion of those in greatest need. Understanding and acceptance of the profound autism concept is critical in terms of serving individuals across the autism spectrum disorder (ASD) spectrum.

Instruction Level: Intermediate
Target Audience:

Behavior analysts

Learning Objectives: At the conclusion of the presentation, participants will be able to: (1) Define “profound autism” as presented by the Lancet Commission and explain why this term was seen as important for ongoing excellence in the field of autism; (2) Discuss the evolution of the ASD diagnosis within the Diagnostic and Statistical Manual (DSM) and some potential shortcomings of the DSM5 ASD diagnosis; (3) Discuss multiple issues that may particularly impact those with profound autism and their families, including medical, psychiatric and behavioral comorbidities, adaptive deficits and need for lifelong intensive care as well as frequent inability to achieve optimal community integration; (4) Gain insight into the under-representation of profound autism in imperative scientific research; (5) Objectively evaluate some of the opposition to the term “profound autism.”
 
LEE WACHTEL (Kennedy Krieger Institute)
Dr. Wachtel received her undergraduate degree in 1993 in Romance Languages and Literatures from Princeton University, and her medical degree from the Johns Hopkins University School of Medicine in Baltimore, Maryland in 1998. She completed general, and child and adolescent psychiatry training at the University of Maryland psychiatry residency training program in Baltimore. She joined the Kennedy Krieger Institute in 2003, where she serves as Medical Director of the Neurobehavioral Unit, specializing in the care of children, adolescents and young adults with autism and intellectual disability who present with concomitant severe psychiatric and behavioral disturbance. Dr. Wachtel is a Professor of Psychiatry at the Johns Hopkins School of Medicine. Her clinical and research interests focus on pediatric catatonia, particularly in autism spectrum disorders, with emphasis on repetitive self-injurious behaviors and optimal catatonia treatment paradigms including electroconvulsive therapy. Dr. Wachtel is the author of more than three dozen scientific manuscripts and textbook chapters, and has lectured extensively throughout the United States and abroad.
 
 
Invited Paper Session #11
CE Offered: PSY/BACB/QABA/NASP/IBAO
Support and Advocacy for People With Profound Autism
Saturday, January 18, 2025
2:30 PM–3:20 PM
Sheraton New Orleans, Level 3, Napoleon Ballroom BC
📺   Streaming Status: recording available
Area: AUT; Domain: Service Delivery
Chair: Terry S. Falcomata (The University of Texas at Austin)
CE Instructor: Terry S. Falcomata, Ph.D.
Presenting Author: JUDITH URSITTI (Profound Autism Alliance)
Abstract:

Profound autism is a newly established administrative term that describes a subset of the autism spectrum that is frequently misunderstood, misrepresented, and excluded. Understanding what this administrative term means and how it can be utilized to design and implement individualized, evidence-based services for the population it represents is vital. Additionally, advocating for meaningful supports and services for people with profound autism requires knowledge of and a unique strategic perspective.

Instruction Level: Basic
Target Audience:

Autism service providers, caregivers, community-members

Learning Objectives: At the conclusion of the presentation, participants will be able to: (1) Describe what the administrative term, profound autism, means; (2) Describe how clinical practice guidelines for applied behavior analysis addresses ways to serve this population; (3) Describe what the current prevalence rate is of people with profound autism in the US; (4) Describe two effective advocacy approaches to ensure this population is represented and supported on both the federal and state levels.
 
JUDITH URSITTI (Profound Autism Alliance)
Judith Ursitti is cofounder and president of Profound Autism Alliance. A CPA by training, she spent a decade working in tax accounting. She became immersed in autism advocacy in 2005 when her son, Jack, was diagnosed at age 2. Since his diagnosis, she has worked on the passage, implementation, and enforcement of autism insurance reform as part of the team that passed legislation in all 50 states. She has advocated federally for the original 2006 passage and subsequent reauthorizations of the Autism CARES Act and appropriate enforcement of the Mental Health Parity and Addiction Equity Act. Judith worked for Autism Speaks as their director of state government affairs for over a decade and served on the Massachusetts Autism Commission, where she co-chaired the Commission’s 14-22/Employment Subcommittee. Most recently, she served as vice president of government affairs at the Council of Autism Service Providers. She is the recipient of the Margaret Bauman, MD Award for Excellence within the Autism Community, the Advocates for Autism of Massachusetts Commitment to Advocacy Award, the Autism Advocacy in Action Award from the Long Island Behavior Analysis Conference, the Oklahoma Autism Network’s Excellence in Autism Award, UMass Medical School’s Autism Insurance Resource Champion Award, and the Autism Science Foundation’s Caryn Schwartzman Spirit Award. She has also run ten marathons, including seven Bostons, fundraising for various autism-related charities. Judith grew up in Texas and remains a Texan at heart, but lives outside Boston with her husband, Andy, and son, Jack.
 
 
Invited Paper Session #12
CE Offered: PSY/BACB/QABA/NASP/IBAO — 
Ethics
The Ethical Use of Biomedical Interventions for Autism
Saturday, January 18, 2025
3:50 PM–4:40 PM
Sheraton New Orleans, Level 3, Napoleon Ballroom BC
📺   Streaming Status: recording available
Area: AUT; Domain: Applied Research
Chair: Terry S. Falcomata (The University of Texas at Austin)
CE Instructor: Terry S. Falcomata, Ph.D.
Presenting Author: JENNIFER R. ZARCONE (The May Institute)
Abstract:

There are many interventions that have been recommended as interventions for challenging behavior andpsychological and behavioral concerns related to autism. Some have clinical trials and other evidence-based research to support their use, but many do not. In this presentation we will discuss some of the recent research on the psychotropic medications, supplements, and other biomedical treatments that have been recommended to families and autistic individuals. We will discuss how we can wade through the information on social media supporting claims and how we can work with families and providers to understand what works and what doesn't.

Instruction Level: Basic
Target Audience:

Practitioners, families, providers, and autistic individuals

Learning Objectives: At the conclusion of the presentation, participants will be able to: (1) Use a set of criteria for evaluating biomedical interventions related to autism; (2) Work with families and other stakeholders to evaluate the effects of biomedical interventions in an ethical way; (3) Work with community providers in a collaborative way to identify effective interventions.
 
JENNIFER R. ZARCONE (The May Institute)
Jennifer Zarcone is currently the Chief Clinical Officer and the Director of the National Autism Center at the May Institute. Dr. Zarcone provides consultation and clinical support to staff around severe problem behavior, staff training, and developing and maintaining clinical service standards. Dr. Zarcone has served in several leadership positions for the Association of Behavior Analysis (ABAI), including co-chair of the ABAI Autism Conference, and is a Fellow of ABAI. She served as an Associate Editor for the Journal of Applied Behavior Analysis, the Journal of Intellectual Disabilities Research, and the American Journal of Intellectual and Developmental Disabilities. She has been on the advisory board of Women in Behavior Analysis for 5 years.
 
 
Invited Paper Session #13
CE Offered: BACB/NASP/IBAO — 
Ethics
Bridging Cultures: Language Assessment and Intervention Strategies for Linguistically Diverse Learners
Saturday, January 18, 2025
4:50 PM–5:40 PM
Sheraton New Orleans, Level 3, Napoleon Ballroom BC
📺   Streaming Status: recording available
Area: AUT; Domain: Service Delivery
Chair: M. Christopher Newland (Auburn University)
CE Instructor: M. Christopher Newland, Ph.D.
Presenting Author: ROCÍO ROSALES (University of Massachusetts Lowell)
Abstract:

All behavior analysis practitioners work with learners and families from diverse backgrounds; however, training programs may not adequately prepare students to work with culturally and linguistically diverse learners. Additionally, pervasive myths and misconceptions about these learners may impact clinical decision-making. This presentation will review these myths and misconceptions and describe how they can affect learning outcomes and hinder culturally responsive practices. Drawing from research in behavior analysis, key areas will be explored to highlight the tangible impacts of the language of instruction on linguistically diverse learners. The presenter will discuss the importance of collaborative interdisciplinary practices in developing and implementing effective language support strategies.

Instruction Level: Basic
Target Audience:

BCBAs, BCaBAs, graduate and undergraduate students, related service professionals

Learning Objectives: At the conclusion of the presentation, participants will be able to: (1) Identify common myths and misconceptions about linguistically diverse learners; (2) Describe culturally responsive language assessment and intervention techniques for these learners; (3) Discuss the role of interdisciplinary collaboration in enhancing language support and intervention outcomes.
 
ROCÍO ROSALES (University of Massachusetts Lowell)
Rocío Rosales, PhD, BCBA-D, LABA, is an Associate Professor of Psychology and Program Coordinator of the Applied Behavior Analysis and Autism Studies graduate program at the University of Massachusetts Lowell. She received her bachelor’s degree from the University of Nevada Reno, and master’s and doctoral degrees from Southern Illinois University, Carbondale. Her research, clinical, and theoretical interests span a range of topics including applications of verbal behavior and derived stimulus relations, student and caregiver training, instructional design, issues of diversity, equity, inclusion, and belonging in ABA, and the philosophical foundations of behavior analysis. She previously served as Associate Editor for The Analysis of Verbal Behavior and The Psychological Record, and on the editorial board of the Journal of Applied Behavior Analysis. She is currently Section Co-Coordinator of ABAI’s Behavior Dissemination Blog: Verbal Behavior Matters. Dr. Rosales has worked to raise awareness of behavior analysis to underserved communities through various projects and professional collaborations and is currently leading a training grant from the U.S. Department of Education, Office of Special Education Programs that will serve to fund scholars in interdisciplinary professional preparation in Applied Behavior Analysis and Special Education. One of the project's main goals is to diversify the workforce and train practitioners to work with bilingual learners with disabilities.
 

BACK TO THE TOP

 

Back to Top
ValidatorError
  
Modifed by Eddie Soh
DONATE
{"isActive":false}